Risk factors for subclinical carotid atherosclerosis among current smokers

Preventive Cardiology

Volumn 13, Issue 4, 2010, Pages 166-171

  Johnson, Heather M ^a   Piper, Megan E ^a   Jorenby, Douglas E ^a   Fiore, Michael C ^a   Baker, Timothy B ^a   Stein, James H ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CAROTID ARTERY; CAROTID ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE;

ADULT; BODY MASS INDEX; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; REGRESSION ANALYSIS; RISK FACTORS; SMOKING; SYSTOLE; TUNICA INTIMA; TUNICA MEDIA;

EID: 77957106754     PISSN: 1520037X     EISSN: 17517141     Source Type: Journal    
DOI: 10.1111/j.1751-7141.2010.00068.x     Document Type: Article

References (25)

1. Burns DM. Epidemiology of smoking-induced cardiovascular disease. Prog Cardiovasc Dis 2003, 46(1):11-29.
2. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease. J Am Coll Cardiol 2004, 43(10):1731-1737.
3. Benowitz N. Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment. Prog Cardiovasc Dis 2003, 46(1):91-111.
4. Lorenz MW, Markus HS, Bots ML. Prediction of clinical cardiovascular events with carotid intima-media thickness. Circulation 2007, 115(4):459-467.
5. Wyman RA, Mays ME, McBride PE. Ultrasound-detected carotid plaque as a predictor of cardiovascular events. Vasc Med 2006, 11:123-130.
6. Howard G, Burke GL, Szklo M. Active and passive smoking are associated with increased carotid wall thickness. The Atherosclerosis Risk in Communities Study. Arch Intern Med 1994, 154(11):1277-1282.
7. Johnson HM, Douglas PS, Srinivasan SR. Predictors of carotid intima-media thickness progression in young men and women: the Bogalusa Heart Study. Stroke 2007, 38(3):900-905.
8. Tzou WS, Douglas PS, Srinivasan SR. Distribution and predictors of carotid artery intima-media thickness in young adults: the Bogalusa Heart Study. Prev Cardiol 2007, 10:181-189.
9. Piper ME, Smith SS, Schlam TR. A randomized placebo-controlled clinical trial of five smoking cessation pharmacotherapies. Arch Gen Psychiatry 2009, 66:1253-1262.
10. Jeyarajah EJ, Cromwell WC, Otvos JD. Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clin Lab Med 2006, 26:847-870.
11. Tzou WS, Korcarz CE, Aeschlimann SE. Use of handheld ultrasound by a non-sonographer clinician to measure carotid intima-media thickness. J Am Soc Echocardiogr 2006, 19(10):1286-1292.
12. Stein JH, Korcarz CE, Hurst RT. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. J Am Soc Echocardiogr 2008, 21(2):93-111.
13. Stein JH, Korcarz CE, Mays ME. A semi-automated border detection program that facilitates clinical use of ultrasound carotid intima-media thickness measurements. J Am Soc Echocardiogr 2005, 18(3):244-251.
14. Heatherton TF, Kozlowski LT, Frecker RC. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Addiction 1991, 86(9):1119-1127.
15. Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 1998, 54:1063-1070.
16. Patrick CJ, Curtin JJ, Tellegen A. Development and validation of a brief form of the Multidimensional Personality Questionnaire. Psychol Assess 2002, 14(2):150-163.
17. Howard G, Sharett A, Heiss G. Carotid artery intimal-media thickness distribution in general populations as evaluated by B-mode ultrasound. Stroke 1993, 24:1297-1304.
18. Mora S, Skzlo M, Otvos JD. LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 2007, 192(1):211-217.
19. Berenson GS, Srinivasan SR, Bao W. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults: the Bogalusa Heart Study. N Engl J Med 1998, 338(23):1650-1656.
20. Sharrett AR, Coady SA, Folsom AR. Smoking and diabetes differ in their associations with subclinical atherosclerosis and coronary heart disease - the ARIC Study. Atherosclerosis 2004, 172:143-149.
21. Campbell SC, Moffatt R, Stamford B. Smoking and smoking cessation - the relationship between cardiovascular disease and lipoprotein metabolism: a review. Atherosclerosis 2008, 201:225-235.
22. Grundy SM. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 2004, 89(6):2595-2600.
23. Nabi H, Kivimaki M, De Vogli R. Positive and negative affect and risk of coronary heart disease: Whitehall II prospective cohort study. BMJ 2008, 337:a118.
24. Chang PP, Ford DE, Meoni LA. Anger in young men and subsequent premature cardiovascular disease. The Precursors Study. Arch Intern Med 2002, 162:901-906.
25. Etter JF, Perneger TV, Ronchi A. Distributions of smokers by stage: international comparison and association with smoking prevalence. Prev Med 1997, 26:580-585.